Bank of Montreal
ELDN icon

Bank of Montreal’s Eledon Pharmaceuticals ELDN Stock Holding History

Bank of Montreal’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Hold
0
– – – 4027
2016
Q4 		– Hold
0
– – – 4080
2016
Q3 		– Hold
0
– – – 4061
2016
Q2 		– Sell
-2
Closed -$2.21K – 4143
2016
Q1 		$1K Buy
+2
New +$1.96K ﹤0.01% 4058
2015
Q4 		– Hold
0
– – – 4265
2015
Q3 		– Hold
0
– – – 4013
2015
Q2 		– Hold
0
– – – 3962
2015
Q1 		– Sell
-49
Closed -$118K – 4026
2014
Q4 		$118K Hold
49
– – ﹤0.01% 2691
2014
Q3 		$121K Buy
+49
New +$139K ﹤0.01% 2732

Other funds holding ELDN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Bank of Montreal's ELDN Position: Q1 2017 in Review

Bank of Montreal held its Eledon Pharmaceuticals (ELDN) position steady in Q1 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4027.

Bank of Montreal first reported a position in ELDN in Q3 2014 and has held it in 3 quarters since. The position peaked at $121K in Q3 2014. 34 funds tracked by Wall St. Rank hold ELDN as of Q1 2017.

  • Bank of Montreal held 0 shares of Eledon Pharmaceuticals worth $0 as of Q1 2017.
  • Bank of Montreal left its Eledon Pharmaceuticals share count unchanged in Q1 2017.
  • Eledon Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2017, its #4027 holding.
  • Bank of Montreal first reported a position in Eledon Pharmaceuticals in Q3 2014 and has held it in 3 quarters since.
  • Bank of Montreal's Eledon Pharmaceuticals position peaked at $121K in Q3 2014.
  • 34 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2017.

Based on Bank of Montreal's 13F filing for Q1 2017, filed 11 Apr 2017.